Back to top
more

CryoPort (CYRX)

(Delayed Data from NSDQ)

$16.47 USD

16.47
435,163

-0.32 (-1.91%)

Updated Apr 18, 2024 04:00 PM ET

After-Market: $16.46 -0.01 (-0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy18.00%
3Hold9.44%
4Sell5.10%
5Strong Sell2.53%
S&P50011.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 4% (241 out of 251)

Industry: Transportation - Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for CYRX

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

CryoPort, Inc. [CYRX]

Reports for Purchase

Showing records 1 - 20 ( 192 total )

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 1

03/13/2024

Company Report

Pages: 12

Slow Growth and Fast Investments Weigh on Near-Term PL

Provider: Roth Capital Partners, Inc.

Analyst: BALDRY R

Price: 25.00

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 2

01/30/2024

Industry Report

Pages: 7

Modest 2H23 Returns Add To Fair 1H23 Returns; 2024 Poised for Material Rebound

Provider: Roth Capital Partners, Inc.

Analyst: BALDRY R

Price: 25.00

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 3

12/08/2023

Daily Note

Pages: 9

Morning Call

Provider: KeyBanc Capital Markets

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 4

12/07/2023

Daily Note

Pages: 14

Life Science Technology: Today''s FDA Approvals Setting CGT Record - Tool Beneficiary Overview

Provider: KeyBanc Capital Markets

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 5

11/21/2023

Company Report

Pages: 6

Optimized Entry and Exit Levels for CYRX 112123

Provider: Stock Traders Daily

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 6

11/09/2023

Daily Note

Pages: 17

Morning Summary

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 7

11/09/2023

Company Report

Pages: 13

Signs Of Stabilization Emerging

Provider: Roth Capital Partners, Inc.

Analyst: BALDRY R

Price: 25.00

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 8

11/09/2023

Daily Note

Pages: 12

Morning Call

Provider: KeyBanc Capital Markets

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 9

11/08/2023

Company Report

Pages: 8

3Q23 Suggests Cell Gene Therapy Market Has Bottomed

Provider: KeyBanc Capital Markets

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 10

10/24/2023

Industry Report

Pages: 4

Technology -12th Annual New York Technology Conference Preview - November 15th

Provider: Roth Capital Partners, Inc.

Analyst: BALDRY R

Price: 5.00

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 11

09/12/2023

Daily Note

Pages: 6

Morning Call

Provider: KeyBanc Capital Markets

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 12

09/11/2023

Daily Note

Pages: 4

Facility Tour - Compelling Perspective on Cell and Gene Therapy Market

Provider: KeyBanc Capital Markets

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 13

08/21/2023

Daily Note

Pages: 6

Morning Call

Provider: KeyBanc Capital Markets

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 14

08/10/2023

Daily Note

Pages: 16

Morning Summary

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 15

08/10/2023

Daily Note

Pages: 6

Research Summary

Provider: KeyBanc Capital Markets

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 16

08/10/2023

Company Report

Pages: 13

Results Match Previewed Weakness

Provider: Roth Capital Partners, Inc.

Analyst: BALDRY R

Price: 25.00

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 17

08/10/2023

Company Report

Pages: 9

2Q23 - Long-Term Outlook on Cell Therapy Market Seems Unchanged

Provider: KeyBanc Capital Markets

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 18

07/17/2023

Daily Note

Pages: 6

Morning Call

Provider: KeyBanc Capital Markets

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 19

07/16/2023

Company Report

Pages: 10

What''s to Be Done with MVE? Downgrade to Sector Weight

Provider: KeyBanc Capital Markets

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: CryoPort, Inc.

Industry: Transportation - Services

Record: 20

07/13/2023

Daily Note

Pages: 10

Morning Summary

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party